Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Segolene Hescot"'
Autor:
Matthieu Faron, Livia Lamartina, Segolene Hescot, Sophie Moog, Frederic Deschamps, Charles Roux, Rosella Libe, Jerome Durand-Labrunie, Abir Al Ghuzlan, Julien Hadoux, Eric Baudin
Publikováno v:
Endocrine. 77:419-424
Adrenocortical carcinoma (ACC) is a very rare and aggressive malignant disease. Therefore, overall survival (OS) has long been considered as the best endpoint. Yet, a unique endpoint is not optimal to take into account the heterogeneity in tumor prof
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18e2acb6449debbf5ec079604d424022
https://doi.org/10.1007/s12020-022-03128-2
https://doi.org/10.1007/s12020-022-03128-2
Autor:
Bowles Daniel W, Lyudmila Bazhenova, Segolene Hescot, Gunnar Folprecht, Haruko Daga, Erminia Massarelli, Conley Anthony P, Livia Lamartina, Jessica Lin, Eugene Ahn, Stuart Osborne, Sebastian Heinzmann, Daniel Carrizosa
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c33593a22e302263a3b562f3b2b3ae80
https://doi.org/10.1530/endoabs.84.op-03-14
https://doi.org/10.1530/endoabs.84.op-03-14
Autor:
Segolene Hescot, Matthieu Faron, Manal Kordahi, Christine Do Cao, Annabelle Naman, Livia Lamartina, Julien Hadoux, Sophie Leboulleux, Francois Pattou, Sébastien Aubert, Jean-Yves Scoazec, Abir Al Ghuzlan, Eric Baudin
Publikováno v:
Cancers; Volume 14; Issue 9; Pages: 2225
Advanced adrenocortical carcinoma (ACC) has poor but heterogeneous prognosis. Apart from Ki67 index, no prognostic or predictive biomarker has been validated in advanced ACC, so far. We aimed at analyzing expression of a large panel of proteins invol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cad2abe8ccd6dfbceac22d3ded2dc73
https://doi.org/10.3390/cancers14092225
https://doi.org/10.3390/cancers14092225
Autor:
Célia Dupain, Tom Gutman, Elodie Girard, Choumouss Kamoun, Grégoire Marret, Zahra Castel-Ajgal, Marie-Paule Sablin, Cindy Neuzillet, Edith Borcoman, Ségolène Hescot, Céline Callens, Olfa Trabelsi-Grati, Samia Melaabi, Roseline Vibert, Samantha Antonio, Coralie Franck, Michèle Galut, Isabelle Guillou, Maral Halladjian, Yves Allory, Joanna Cyrta, Julien Romejon, Eleonore Frouin, Dominique Stoppa-Lyonnet, Jennifer Wong, Christophe Le Tourneau, Ivan Bièche, Nicolas Servant, Maud Kamal, Julien Masliah-Planchon
Publikováno v:
BMC Biology, Vol 22, Iss 1, Pp 1-12 (2024)
Abstract Background High tumor mutational burden (TMB) was reported to predict the efficacy of immune checkpoint inhibitors (ICIs). Pembrolizumab, an anti-PD-1, received FDA-approval for the treatment of unresectable/metastatic tumors with high TMB a
Externí odkaz:
https://doaj.org/article/38a817e5035043189c5b339051b10be7
Autor:
Segolene, Hescot, Hala, Sheikh-Alard, Manal, Kordahi, Dana, Hartl, Julien, Hadoux, Marie, Terroir, Ingrid, Breuskin, Eric, Baudin, Jean-Yves, Scoazec, Martin, Schlumberger, Abir, Al Ghuzlan, Sophie, Leboulleux
Publikováno v:
Endocrine. 72(3)
Histologic and pTNM classification of differentiated thyroid cancer (DTC) is mandatory to assess risk of relapse, risk of death, and radioactive iodine administration. The impact of an expert central review of external pathology reports has not yet b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2a683518b03d5493fc2091cf12f211ed
https://pubmed.ncbi.nlm.nih.gov/33400174
https://pubmed.ncbi.nlm.nih.gov/33400174
Autor:
Guillaume Gravel, Sophie Leboulleux, Lambros Tselikas, Flora Fassio, Mohamed Berraf, Amandine Berdelou, Bakar Ba, Segolene Hescot, Julien Hadoux, Martin Schlumberger, Abir Al Ghuzlan, France Nguyen, Mathieu Faron, Thierry de Baere, Eric Baudin, Frederic Deschamps
Publikováno v:
Endocrine. 59:547-554
Bone metastases (BM) and skeletal-related events (SRE) are frequent in patients with malignant pheochromocytoma and paraganglioma (PPM) and the best modality of prevention unknown. The role of interventional radiology (IR) techniques for the preventi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af086df58ede61e7ccc4a8930e9c337e
https://doi.org/10.1007/s12020-017-1515-y
https://doi.org/10.1007/s12020-017-1515-y
Autor:
Serena, Grimaldi, Jacques, Young, Peter, Kamenicky, Dana, Hartl, Marie, Terroir, Sophie, Leboulleux, Amandine, Berdelou, Julien, Hadoux, Segolene, Hescot, Hervé, Remy, Eric, Baudin, Martin, Schlumberger, Désirée, Deandreis
Publikováno v:
European journal of nuclear medicine and molecular imaging. 45(10)
To evaluate the added value ofWe included 27 consecutive patients with primary HPT (19 F; median age: 58 years), with either (i) non-conclusive pre-surgical localization with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bad91c7ecf721b45ec8b4220932cfe22
https://pubmed.ncbi.nlm.nih.gov/29680989
https://pubmed.ncbi.nlm.nih.gov/29680989
Autor:
Ségolène Hescot, Julien Masliah-Planchon, Pauline du Rusquec, Célia Dupain, Maud Kamal, Vincent Servois, Ivan Bieche
Publikováno v:
European Thyroid Journal, Vol 11, Iss 5, Pp 1-3 (2023)
Medullary thyroid carcinoma (MTC) is a rare but aggressive thyroid tumor, with 25% of hereditary and 75% of sporadic forms. RET mutations are found in 98% of hereditary MTC and in 55% of sporadic MTC (1). The most frequent somatic RET mutation occurs
Externí odkaz:
https://doaj.org/article/120685819d9a4b3abbc44e391fba82eb
Publikováno v:
European Thyroid Journal, Vol 11, Iss 6, Pp 1-2 (2023)
A 46-year-old female presented with a 4-month history of 5–30 mm subcutaneous nodules in the right supraclavicular, axillary, and pectoral areas (Fig. 1). She had undergone a lobo-isthmectomy for a 20 mm right follicular adenoma performed 8 years e
Externí odkaz:
https://doaj.org/article/90a48f30067b47d0b63240c82efc05c8
Autor:
Célia Dupain, Julien Masliah‐Planchon, Céline Gu, Elodie Girard, Pierre Gestraud, Pauline Du Rusquec, Edith Borcoman, Diana Bello, Francesco Ricci, Ségolène Hescot, Marie‐Paule Sablin, Patricia Tresca, Alexandre deMoura, Delphine Loirat, Maxime Frelaut, Anne Vincent‐Salomon, Charlotte Lecerf, Céline Callens, Samantha Antonio, Coralie Franck, Odette Mariani, Ivan Bièche, Maud Kamal, Christophe Le Tourneau, Vincent Servois
Publikováno v:
Molecular Oncology, Vol 15, Iss 1, Pp 104-115 (2021)
High‐throughput molecular profiling of solid tumours using core needle biopsies (CNB) allows the identification of actionable molecular alterations, with around 70% success rate. Although several studies have demonstrated the utility of small biops
Externí odkaz:
https://doaj.org/article/fd5e3a2e632f4a30ae0bd88e27294874